GW&K Investment Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10.2M | Sell |
40,704
-737
| -2% | -$183K | 0.09% | 254 |
|
|
2025
Q4 | $11.4M | Buy |
41,441
+40,577
| +4,696% | +$11.1M | 0.1% | 252 |
|
|
2025
Q3 | $227K | Sell |
864
-3
| -0.3% | -$729 | ﹤0.01% | 382 |
|
|
2025
Q2 | $190K | Buy |
867
+4
| +0.5% | +$855 | ﹤0.01% | 382 |
|
|
2025
Q1 | $193K | Sell |
863
-12
| -1% | -$3.31K | ﹤0.01% | 377 |
|
|
2024
Q4 | $287K | Sell |
875
-2,472
| -74% | -$778K | ﹤0.01% | 356 |
|
|
2024
Q3 | $1M | Sell |
3,347
-30,267
| -90% | -$9.27M | 0.01% | 319 |
|
|
2024
Q2 | $11.1M | Sell |
33,614
-631
| -2% | -$223K | 0.1% | 245 |
|
|
2024
Q1 | $13.6M | Buy |
34,245
+298
| +0.9% | +$110K | 0.12% | 231 |
|
|
2023
Q4 | $12M | Sell |
33,947
-12,421
| -27% | -$4.4M | 0.11% | 235 |
|
|
2023
Q3 | $17.4M | Sell |
46,368
-4,951
| -10% | -$1.91M | 0.17% | 193 |
|
|
2023
Q2 | $19.6M | Sell |
51,319
-35,214
| -41% | -$12.6M | 0.19% | 188 |
|
|
2023
Q1 | $30M | Buy |
86,533
+1,127
| +1% | +$329K | 0.29% | 145 |
|
|
2022
Q4 | $20.1M | Buy |
85,406
+38,806
| +83% | +$9.2M | 0.2% | 174 |
|
|
2022
Q3 | $11.5M | Buy |
46,600
+40,607
| +678% | +$12.4M | 0.13% | 198 |
|
|
2022
Q2 | $1.81M | Buy |
5,993
+53
| +0.9% | +$17.2K | 0.02% | 313 |
|
|
2022
Q1 | $2.44M | Buy |
5,940
+3,506
| +144% | +$1.37M | 0.02% | 304 |
|
|
2021
Q4 | $1.14M | Sell |
2,434
-35
| -1% | -$15.1K | 0.01% | 320 |
|
|
2021
Q3 | $1.05M | Buy |
2,469
+4
| +0.2% | +$1.69K | 0.01% | 324 |
|
|
2021
Q2 | $885K | Sell |
2,465
-69
| -3% | -$22.8K | 0.01% | 329 |
|
|
2021
Q1 | $714K | Buy |
2,534
+1,344
| +113% | +$385K | 0.01% | 332 |
|
|
2020
Q4 | $337K | Sell |
1,190
-89,967
| -99% | -$25.2M | ﹤0.01% | 330 |
|
|
2020
Q3 | $25.1M | Sell |
91,157
-160,060
| -64% | -$42.4M | 0.33% | 129 |
|
|
2020
Q2 | $57.1M | Sell |
251,217
-100,050
| -28% | -$19.7M | 0.8% | 21 |
|
|
2020
Q1 | $53.5M | Buy |
351,267
+16,899
| +5% | +$2.6M | 0.94% | 17 |
|
|
2019
Q4 | $50.3M | Sell |
334,368
-9,564
| -3% | -$1.39M | 0.67% | 31 |
|
|
2019
Q3 | $48.8M | Sell |
343,932
-252
| -0.1% | -$34.7K | 0.69% | 30 |
|
|
2019
Q2 | $43.1M | Sell |
344,184
-5,240
| -1% | -$619K | 0.65% | 33 |
|
|
2019
Q1 | $38.5M | Buy |
349,424
+5,580
| +2% | +$580K | 0.62% | 40 |
|
|
2018
Q4 | $33.7M | Buy |
343,844
+6,585
| +2% | +$715K | 0.67% | 39 |
|
|
2018
Q3 | $41.6M | Sell |
337,259
-1,707
| -0.5% | -$191K | 0.67% | 37 |
|
|
2018
Q2 | $33.7M | Sell |
338,966
-5,361
| -2% | -$493K | 0.55% | 58 |
|
|
2018
Q1 | $30.4M | Sell |
344,327
-538,469
| -61% | -$50.4M | 0.51% | 67 |
|
|
2017
Q4 | $87.1M | Sell |
882,796
-74,645
| -8% | -$7.32M | 1.49% | 3 |
|
|
2017
Q3 | $92.2M | Buy |
957,441
+940
| +0.1% | +$85.1K | 1.54% | 1 |
|
|
2017
Q2 | $90.4M | Sell |
956,501
-50,354
| -5% | -$4.63M | 1.56% | 2 |
|
|
2017
Q1 | $82.2M | Sell |
1,006,855
-18,400
| -2% | -$1.54M | 1.55% | 2 |
|
|
2016
Q4 | $87M | Sell |
1,025,255
-83,194
| -8% | -$6.54M | 1.69% | 2 |
|
|
2016
Q3 | $82.6M | Sell |
1,108,449
-52,078
| -4% | -$4.13M | 1.55% | 4 |
|
|
2016
Q2 | $88.1M | Sell |
1,160,527
-19,651
| -2% | -$1.43M | 1.82% | 2 |
|
|
2016
Q1 | $81.8M | Buy |
1,180,178
+26,956
| +2% | +$1.62M | 1.81% | 2 |
|
|
2015
Q4 | $69.4M | Sell |
1,153,222
-32,074
| -3% | -$1.93M | 1.63% | 3 |
|
|
2015
Q3 | $64.1M | Buy |
1,185,296
+46,017
| +4% | +$2.68M | 1.53% | 3 |
|
|
2015
Q2 | $66.2M | Sell |
1,139,279
-23,574
| -2% | -$1.32M | 1.51% | 4 |
|
|
2015
Q1 | $70M | Sell |
1,162,853
-9,321
| -0.8% | -$497K | 1.59% | 3 |
|
|
2014
Q4 | $62.4M | Buy |
1,172,174
+33,006
| +3% | +$1.65M | 1.49% | 4 |
|
|
2014
Q3 | $51M | Buy |
1,139,168
+111,792
| +11% | +$4.75M | 1.34% | 7 |
|
|
2014
Q2 | $43.3M | Buy |
1,027,376
+50,994
| +5% | +$2.18M | 1.1% | 23 |
|
|
2014
Q1 | $43M | Buy |
976,382
+261
| +0% | +$12.3K | 1.15% | 15 |
|
|
2013
Q4 | $47.9M | Buy |
976,121
+26,375
| +3% | +$1.23M | 1.3% | 11 |
|
|
2013
Q3 | $39.1M | Buy |
949,746
+136,188
| +17% | +$5.2M | 1.19% | 17 |
|
|
2013
Q2 | $28.6M | Buy |
+813,558
| New | +$26.8M | 1.06% | 21 |
|
Other funds holding WST
VCM
VPM
GIM
GW&K Investment Management's WST Position: Q1 2026 in Review
GW&K Investment Management reduced its West Pharmaceutical (WST) stake by 1.8% in Q1 2026, selling an estimated $183K and leaving 40,704 shares worth $10.2M. The position accounts for 0.09% of the portfolio, ranked #254.
GW&K Investment Management first reported a position in WST in Q2 2013 and has held it in 52 quarters since. The position peaked at $92.2M in Q3 2017. 754 funds tracked by Wall St. Rank hold WST as of Q1 2026.
- GW&K Investment Management held 40,704 shares of West Pharmaceutical worth $10.2M as of Q1 2026.
- GW&K Investment Management sold 737 West Pharmaceutical shares in Q1 2026, an estimated $183K.
- West Pharmaceutical made up 0.09% of GW&K Investment Management's portfolio in Q1 2026, its #254 holding.
- GW&K Investment Management first reported a position in West Pharmaceutical in Q2 2013 and has held it in 52 quarters since.
- GW&K Investment Management's West Pharmaceutical position peaked at $92.2M in Q3 2017.
- 754 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.
Based on GW&K Investment Management's 13F filing for Q1 2026, filed 13 May 2026.